219 related articles for article (PubMed ID: 29394540)
21. [A Case of Advanced Gastric Cancer Treated Effectively with Combination Chemotherapy of Paclitaxel plus Ramucirumab].
Masano Y; Moriyama H; Murata T; Sato B; Usui Y
Gan To Kagaku Ryoho; 2019 Aug; 46(8):1299-1302. PubMed ID: 31501374
[TBL] [Abstract][Full Text] [Related]
22. [Three Patients with Gastric Cancer Who Underwent Surgery during Ramucirumab Treatment].
Omori H; Kawai S; Makuuchi R; Irino T; Tokunaga M; Tanizawa Y; Bando E; Kawamura T; Yasui H; Terashima M
Gan To Kagaku Ryoho; 2017 Nov; 44(11):1021-1023. PubMed ID: 29138380
[TBL] [Abstract][Full Text] [Related]
23. [Efficacy and Safety of Paclitaxel plus Ramucirumab Therapy for Unresectable or Recurrent Gastric Cancer].
Tsujio G; Toyokawa T; Fukuoka T; Tamura T; Ohira G; Shibutani M; Yamazoe S; Nagahara H; Kimura K; Amano R; Tanaka H; Muguruma K; Yashiro M; Maeda K; Hirakawa K; Ohira M
Gan To Kagaku Ryoho; 2019 May; 46(5):895-899. PubMed ID: 31189811
[TBL] [Abstract][Full Text] [Related]
24. [A Case of Port Site Recurrence after Laparoscopic Distal Gastrectomy for Advanced Gastric Cancer].
Fujita S; Ohki S; Kase K; Yamauchi N; Chida S; Hayase S; Sakamoto W; Monma T; Takawa M; Ohtake T; Kono K; Takenoshita S
Gan To Kagaku Ryoho; 2016 Nov; 43(12):1502-1504. PubMed ID: 28133037
[TBL] [Abstract][Full Text] [Related]
25. [Effect of Hypoalbuminemia on Severe Neutropenia Induced by Paclitaxel Monotherapy and Paclitaxel plus Ramucirumab Combination Therapy in Patients with Gastric Cancer].
Nakazawa Y; Kageyama A; Harada D; Kitamura M; Mitsumori N; Kawakubo T
Gan To Kagaku Ryoho; 2019 May; 46(5):901-905. PubMed ID: 31189812
[TBL] [Abstract][Full Text] [Related]
26. [A case of recurrent gastric cancer with peritoneal dissemination responding to doxifluridine/paclitaxel combination chemotherapy as third-line treatment].
Yagi Y; Ichikawa K; Takahashi K; Okuda N
Gan To Kagaku Ryoho; 2007 Feb; 34(2):261-3. PubMed ID: 17301540
[TBL] [Abstract][Full Text] [Related]
27. [A case of paclitaxel-resistant recurrent gastric cancer responsive to S-1 plus docetaxel].
Nishikawa K; Iwase K; Aono T; Yoshida H; Nomura M; Tamagawa H; Matsuda C; Deguchi T; Kawada J; Higashi S; Deguchi K; Noguchi Y; Okumura Y; Nomura M; Fushimi H; Takagi M; Fukui A; Fujitani K; Endo S; Tanaka Y
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2259-61. PubMed ID: 24394078
[TBL] [Abstract][Full Text] [Related]
28. [Laparoscopic Partial Hepatectomy for the Liver Metastasis of Gastric Cancer after Nab-Paclitaxel plus Ramucirumab Combination Therapy-A Case Report].
Chuman M; Takahashi Y; Tokito T; Maruyama M; Chino S; Ushiku H; Nakamura K; Naito M; Kondo Y; Yamazaki H; Nishi Y; Hiki N
Gan To Kagaku Ryoho; 2020 Dec; 47(13):2065-2067. PubMed ID: 33468802
[TBL] [Abstract][Full Text] [Related]
29. Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: the ARMANI phase III trial.
Di Bartolomeo M; Niger M; Morano F; Corallo S; Antista M; Tamberi S; Lonardi S; Di Donato S; Berardi R; Scartozzi M; Cardellino GG; Di Costanzo F; Rimassa L; Luporini AG; Longarini R; Zaniboni A; Bertolini A; Tomasello G; Pinotti G; Scagliotti G; Tortora G; Bonetti A; Spallanzani A; Frassineti GL; Tassinari D; Giuliani F; Cinieri S; Maiello E; Verusio C; Bracarda S; Catalano V; Basso M; Ciuffreda L; De Vita F; Parra HS; Fornaro L; Caporale M; de Braud F; Pietrantonio F
BMC Cancer; 2019 Mar; 19(1):283. PubMed ID: 30922323
[TBL] [Abstract][Full Text] [Related]
30. Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites.
Kitayama J; Ishigami H; Yamaguchi H; Yamashita H; Emoto S; Kaisaki S; Watanabe T
Ann Surg Oncol; 2014 Feb; 21(2):539-46. PubMed ID: 23975319
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of ramucirumab plus paclitaxel therapy for advanced gastric cancer patients treated previously with docetaxel-containing chemotherapy.
Kakuta T; Yabusaki H; Bamba T; Aizawa M; Nogami H; Nomura T; Matsuki A; Maruyama S; Takii Y; Nakagawa S
Int J Clin Oncol; 2021 Apr; 26(4):684-693. PubMed ID: 33389346
[TBL] [Abstract][Full Text] [Related]
32. [Successful management with S-1 of recurrent gastric cancer after adjuvant chemotherapy with paclitaxel/UFT].
Tokunaga Y; Sasaki H; Saito T
Gan To Kagaku Ryoho; 2010 Apr; 37(4):703-6. PubMed ID: 20414030
[TBL] [Abstract][Full Text] [Related]
33. Real-World Effectiveness and Safety of Ramucirumab as a Second-Line Treatment for Patients with Unresectable Advanced or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma in Japan and South Korea: A Systematic Literature Review.
Zhang X; Zhou L; Zhou C; Shen L
Adv Ther; 2024 Jun; 41(6):2112-2132. PubMed ID: 38619719
[TBL] [Abstract][Full Text] [Related]
34. Nanoparticle albumin-bound paclitaxel and ramucirumab versus paclitaxel and ramucirumab as second-line chemotherapy for unresectable advanced or recurrent gastric cancer: a multicenter, propensity score-matched analysis (CROSS SELL study).
Nakasya A; Hagiwara Y; Ikoma T; Kurioka Y; Matsumoto T; Yamamoto Y; Tsuduki T; Kajiwara T; Moriwaki T; Nishina T; Yamashita N; Hyodo I
Int J Clin Oncol; 2022 Apr; 27(4):684-694. PubMed ID: 35089459
[TBL] [Abstract][Full Text] [Related]
35. [A case of complete remission of carcinomatous ascites refractory for TS-1 monotherapy treated with TS-1 plus paclitaxel combined therapy for gastric cancer].
Imamura H; Furukawa H; Kishimoto T; Miyazaki Y; Yamamoto K; Ohshiro R; Ohta K; Nakata Y; Kamigaki S; Kondo M; Takemoto H; Fujimi S; Nakayama T; Fukunaga M; Ohsato H; Tatsuta M
Gan To Kagaku Ryoho; 2006 Nov; 33(12):1900-3. PubMed ID: 17212141
[TBL] [Abstract][Full Text] [Related]
36. A retrospective study of the safety and efficacy of paclitaxel plus ramucirumab in patients with advanced or recurrent gastric cancer with ascites.
Matsumoto H; Kawazoe A; Shimada K; Fukuoka S; Kuboki Y; Bando H; Kojima T; Ohtsu A; Yoshino T; Doi T; Shitara K
BMC Cancer; 2018 Jan; 18(1):120. PubMed ID: 29385993
[TBL] [Abstract][Full Text] [Related]
37. [The Clinical Effect of Ramucirumab in the Treatment of Advanced Gastric Cancer in Our Hospital].
Kenno S; Takahashi S; Noguchi K; Yamagami H; Ishizu H; Takahashi M
Gan To Kagaku Ryoho; 2018 Jan; 45(1):79-81. PubMed ID: 29362314
[TBL] [Abstract][Full Text] [Related]
38. A feasibility study of sequential paclitaxel and S-1 (PTX/S-1) chemotherapy as postoperative adjuvant chemotherapy for advanced gastric cancer.
Kobayashi M; Tsuburaya A; Nagata N; Miyashita Y; Oba K; Sakamoto J
Gastric Cancer; 2006; 9(2):114-9. PubMed ID: 16767367
[TBL] [Abstract][Full Text] [Related]
39. [Oophorectomy for Ovarian Metastasis Occurring during Chemotherapy in Gastric Cancer Patients with Peritoneal Dissemination--Report of Three Cases].
Ichihara M; Fujiwara Y; Omori T; Miyoshi N; Sugimura K; Akita H; Motoori M; Gotoh K; Takahashi H; Kobayashi S; Noura S; Miyata H; Ohue M; Sakon M; Yano M
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1527-9. PubMed ID: 26805085
[TBL] [Abstract][Full Text] [Related]
40. [A Case of Ramucirumab-Related Small Intestinal Perforation in Gastric Cancer].
Murase H; Oono R; Yoshida T; Ishihara K; Otomo M; Suzuki Y; Hayashi K; Higuchi K; Yoshinouchi S; Kamiya A; Obata M; Ogawa A; Hayashi M; Park S; Iseki H
Gan To Kagaku Ryoho; 2021 Dec; 48(13):1598-1600. PubMed ID: 35046268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
